Plymouth Hospitals NHS Trust Rory Rickard Col Chris Taylor Phil Hughes David Gay Priya Suresh Francis Daniel Mark Smith Abdul Gafoor Liz Ridgeway Ann Davies Udaiveer Panwar Consultant Plastic Surgeon Consultant Surgeon Consultant Radiologist Consultant Radiologist Consultant Radiologist Consultant Clinical Oncologist Consultant Histopathologist Consultant Radiologist Clinical Nurse Specialist Clinical Nurse Specialist Consultant Clinical Oncologist Devon and Exeter NHS Foundation Trust David Silver Peter Bliss Patrick Sarsfield Chris Mills Sarah Sandford Claire Facey Chris Stone Kate Allington Mark Napier Andrew Redfern Consultant Consultant Clinical Oncologist Consultant Histopathologist Consultant Surgeon Clinical Specialist Clinical Specialist Consultant Plastic Surgeon Clinical Specialist Oncologist Radiologist Royal Cornwall NHS Hospitals Trust Toby Talbot Kim Farmer Benjamin Casey Consultant Oncologist Radiologist Clinical Nurse Specialist Devon NHS Foundation Trust Richard Seymour Pam Lewins Consultant Clinical Specialist 4.4 Network Group Membership Membership of the Group will be multi-disciplinary in nature with representation from professionals across the care pathway. All core and extended members of the relevant Acute Trust MDT(s) are invited to participate in Group activities via Group meetings, working parties and email communications as appropriate. The Group will work towards developing patient and carer involvement in to the Group and patient and carer representative(s) will be appointed whenever possible. In the absence of patient and carer representatives the appointed patient champion and information lead will support the group to ensure
5.1 Molecular Biology/Cytogenetic Facilities 14-1C-103l, Cytogenetic and molecular biology investigations on sarcoma cases will be provided by the following hospitals: Royal Marsden Hospital: Prof. Cyril Fisher Birmingham Hospital: Chaz Mangham 5.2 Designated GIST Histopathologists 14-1C-108l The designated consultant histopathologists who and only who will be responsible for the final reporting and reviewing of the histological diagnosis of GIST is Dr Bracey, Plymouth Hospitals NHS Trust, who is a Lead Pathologist for the Plymouth Hospitals NHS Trust Upper GI SMDT and participate s in a EQA scheme. 6. Coordination of Care/Patient Pathways Primary Care Referral Guidelines Primary Care practitioners will refer all patients defined by the “urgent, suspicious of cancer” guidelines for sarcomas to the contact point at the local designated Diagnostic Clinic. 6.2 Referral Guidelines for Patients Moving Between Referring clinicians should ensure that all relevant information is provided to facilitate the continuity of care and avoid unnecessary delays. The Peninsula Tertiary Referral Form (TRF01) should be used when referring patients to another Acute Trust for specialist investigation or treatment and sent within one working day of the referral being made see PCN information policy to support data transfer, this form accompanies the clinical referral. ? Patients with synchronous sarcomas and cancers at other sites Such patients will be discussed in the Sarcoma MDT. Lead responsibility will be shared with the other MDT, until it becomes clear which MDT would be best to lead in each individual case. Network guidelines will be reviewed at least every three years or on the publication of new guidance. It is the responsibility of the of the Group to ensure that all Network guidelines are up to date and reflect current practice. 6.3 Clinical Guidelines for Soft Tissue Sarcoma – Limb & Trunk 14-1C-109l The Sarcoma Group has agreed clinical guidelines for the management of soft tissue sarcoma. The Group has adopted the Peninsula Radiotherapy Guidelines and Protocols for soft tissue sarcoma.
3.6. Notes Notes will be produced for each meeting capturing; Attendance; Actions for Group members; Agreements; Recommendations for commissioners or providers. Draft notes, agreed by the Chair, will be circulated within one month of the meeting. 4. Accountability The Group will report to the Clinical Directors for Cancer in the Peninsula Cancer Network but will also be accountable to the South West Cancer Steering Group, which will set the priorities and strategy for Cancer in the South West. Groups should request commissioning decisions via the South West Cancer Network Manager, who will facilitate a collective commissioning response – using the Steering Group where necessary. 4.1. Communication The following documents will be made public on the West Cancer Network website Meeting papers Agreed documents (guidelines, protocols etc.) Peer Review documents will be available on the Peer Review website .